Magdalena Diversifies into Biological Manufacturing
Latam sugar giant Magdalena is embarking on a significant transformation, moving beyond traditional sugar production, ethanol, and energy. The company is set to construct a 650,000-liter precision fermentation facility in Guatemala, alongside ventures in value-added protein production from spent yeast and a biochem unit in Portugal.
Strategic Shift in Operations
This diversification represents a strategic pivot aimed at minimizing exposure to the volatile sugar market. By repositioning itself as a producer of high-value ingredients, Magdalena is leveraging its existing infrastructure and feedstocks to reduce production costs.
Three Pillars of New Strategy
The new strategy is built on three foundational pillars:
- Biorbis: An R&D and innovation hub in Portugal, acquired during Amyris’ restructuring.
- Proteva: A venture focused on upcycling spent yeast into functional protein ingredients for animal feed and pet food.
- A contract manufacturing platform in Guatemala, designed to convert sugar into high-value molecules at scale.
Additionally, the company aims to invest in precision fermentation startups through a dedicated ventures arm.
Insights from Industry Leaders
AgFunderNews (AFN) recently interviewed key executives from Magdalena, including Wagner Pinton Ferreira (WPF), head of industrialization, Ligia Castañeda (LC), portfolio manager, and Raquel Madureira (RM), general manager at Biorbis, at the Future Food Tech conference in San Francisco.
Advantages of Facility Location
AFN: What are the benefits of building the precision fermentation facility next to your sugar mill in Guatemala?
WPF: This proximity allows us to reduce transportation costs and leverage shared utilities, logistics, and administration.
LC: With our four-decade presence in the industrial sector, our location offers exceptional access to the US market and both the Pacific and Atlantic Oceans. Moreover, our costs for feedstock and labor are significantly lower than in the US or Europe, enhancing our competitiveness.
Facility Scale-Up Plans
AFN: What’s the scale-up plan for the new precision fermentation facility?
WPF: Our construction will occur in three phases: a pilot facility with 50 cubic meters of capacity by 2027, followed by 200 cubic meters in 2028, and ultimately two more 200 cubic meter fermenters by 2030, totaling 650,000 liters.
Commercial Planning and Downstream Processing
AFN: What’s your commercial plan for the facility?
LC: Our goal is to secure contracts with two or three major companies for regular production, alongside capacity for spot clients.
Investments in Precision Fermentation Startups
AFN: What is Magdalena’s approach to investing in startups in precision fermentation?
LC: We’ve invested in several startups such as Amplifye, VinZymes, and Oobli through our new ventures arm launched in 2023. Our focus is on collaboration and supporting partners across diverse applications.
About Biorbis
AFN: Can you elaborate on Biorbis?
RM: Biorbis serves as a biochemical innovation center that facilitates process development and application testing. With a highly qualified team, we aim to co-create and commercialize ingredients across various sectors, including animal feed, pet food, nutraceuticals, and cosmetics.
The Future of Protein Production
AFN: You also have a business unit called Proteva.
RM: Yes, Proteva focuses on enhancing protein functionality via enzymatic hydrolysis, yielding high-quality nutritional profiles and additional biological benefits from spent yeast.
Conclusion
Magdalena’s strategic shift into biological manufacturing marks a bold step toward innovation in high-value ingredient production. As the company leverages its established infrastructure and invests in emerging technologies, it positions itself to thrive in the evolving landscape of the food and biochem industry.
Further Reading:
- 🎥 21st Bio on strains, scale, and the valley of death: Fixing precision fermentation’s weak links
- 🎥 Future Food-Tech: Big ideas, hard truths, and the path to scale
- 🎥 Investors demand capital efficiency, focus, and no AI-polished pitch decks at World Agri-Tech, Future Food-Tech
- 🎥 Amplifye debuts enzyme to supercharge protein digestion and unlock new health benefits
This structured HTML article maintains a coherent flow and readability while adhering to best practices for web content. Each section is clearly defined with appropriate headings, making it easy for readers to navigate the topics.
